Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
The Effect of Liv.52 DS in Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): A Pilot, Randomized, Double-Blind, Placebo-Controlled, Clinical Study
Saved in:
| Published in: | Hepatic Medicine: Evidence and Research |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2025
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|